ID   ATG4D_HUMAN             Reviewed;         474 AA.
AC   Q86TL0; Q969K0;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   18-JUN-2025, entry version 165.
DE   RecName: Full=Cysteine protease ATG4D {ECO:0000305};
DE            EC=3.4.22.- {ECO:0000269|PubMed:21177865};
DE   AltName: Full=AUT-like 4 cysteine endopeptidase;
DE   AltName: Full=Autophagy-related cysteine endopeptidase 4 {ECO:0000303|PubMed:12446702};
DE            Short=Autophagin-4 {ECO:0000303|PubMed:12446702};
DE   AltName: Full=Autophagy-related protein 4 homolog D {ECO:0000305};
DE            Short=HsAPG4D {ECO:0000303|PubMed:29458288};
DE   Contains:
DE     RecName: Full=Cysteine protease ATG4D, mitochondrial {ECO:0000305};
GN   Name=ATG4D {ECO:0000303|PubMed:19549685, ECO:0000312|HGNC:HGNC:20789};
GN   Synonyms=APG4D {ECO:0000312|HGNC:HGNC:20789}, AUTL4
GN   {ECO:0000312|HGNC:HGNC:20789};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, Ovary, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   RETRACTED PAPER.
RC   TISSUE=Fetal liver;
RX   PubMed=12446702; DOI=10.1074/jbc.m208247200;
RA   Marino G., Uria J.A., Puente X.S., Quesada V., Bordallo J., Lopez-Otin C.;
RT   "Human autophagins, a family of cysteine proteinases potentially implicated
RT   in cell degradation by autophagy.";
RL   J. Biol. Chem. 278:3671-3678(2003).
RN   [5]
RP   RETRACTION NOTICE OF PUBMED:12446702.
RX   PubMed=30808002; DOI=10.1074/jbc.w118.007325;
RA   Marino G., Uria J.A., Puente X.S., Quesada V., Bordallo J., Lopez-Otin C.;
RL   J. Biol. Chem. 294:1431-1431(2019).
RN   [6]
RP   FUNCTION (CYSTEINE PROTEASE ATG4D; MITOCHONDRIAL), CLEAVAGE BY CASP3,
RP   MUTAGENESIS OF ASP-63, AND SUBCELLULAR LOCATION.
RX   PubMed=19549685; DOI=10.1242/jcs.046250;
RA   Betin V.M., Lane J.D.;
RT   "Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers
RT   mitochondrial targeting and apoptosis.";
RL   J. Cell Sci. 122:2554-2566(2009).
RN   [7]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY REGULATION.
RX   PubMed=21177865; DOI=10.1074/jbc.m110.199059;
RA   Li M., Hou Y., Wang J., Chen X., Shao Z.M., Yin X.M.;
RT   "Kinetics comparisons of mammalian Atg4 homologues indicate selective
RT   preferences toward diverse Atg8 substrates.";
RL   J. Biol. Chem. 286:7327-7338(2011).
RN   [8]
RP   FUNCTION (CYSTEINE PROTEASE ATG4D; MITOCHONDRIAL), CLEAVAGE BY CASP3,
RP   SUBCELLULAR LOCATION, DOMAIN, AND CRYPTIC SIGNAL PEPTIDE.
RX   PubMed=22441018; DOI=10.4161/auto.19227;
RA   Betin V.M., MacVicar T.D., Parsons S.F., Anstee D.J., Lane J.D.;
RT   "A cryptic mitochondrial targeting motif in Atg4D links caspase cleavage
RT   with mitochondrial import and oxidative stress.";
RL   Autophagy 8:664-676(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-467, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29458288; DOI=10.1080/15548627.2018.1437341;
RA   Kauffman K.J., Yu S., Jin J., Mugo B., Nguyen N., O'Brien A., Nag S.,
RA   Lystad A.H., Melia T.J.;
RT   "Delipidation of mammalian Atg8-family proteins by each of the four ATG4
RT   proteases.";
RL   Autophagy 14:992-1010(2018).
RN   [11]
RP   FUNCTION.
RX   PubMed=30661429; DOI=10.1080/15548627.2019.1569925;
RA   Agrotis A., Pengo N., Burden J.J., Ketteler R.;
RT   "Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP
RT   processing revealed in cells.";
RL   Autophagy 15:976-997(2019).
RN   [12]
RP   FUNCTION.
RX   PubMed=33773106; DOI=10.1016/j.molcel.2021.03.001;
RA   Nguyen T.N., Padman B.S., Zellner S., Khuu G., Uoselis L., Lam W.K.,
RA   Skulsuppaisarn M., Lindblom R.S.J., Watts E.M., Behrends C., Lazarou M.;
RT   "ATG4 family proteins drive phagophore growth independently of the
RT   LC3/GABARAP lipidation system.";
RL   Mol. Cell 81:2013-2030(2021).
RN   [13]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=33909989; DOI=10.1016/j.molcel.2021.03.020;
RA   Durgan J., Lystad A.H., Sloan K., Carlsson S.R., Wilson M.I., Marcassa E.,
RA   Ulferts R., Webster J., Lopez-Clavijo A.F., Wakelam M.J., Beale R.,
RA   Simonsen A., Oxley D., Florey O.;
RT   "Non-canonical autophagy drives alternative ATG8 conjugation to
RT   phosphatidylserine.";
RL   Mol. Cell 81:2031-2040(2021).
RN   [14]
RP   VARIANTS LEU-125; ILE-273; ASP-295 AND MET-395, CHARACTERIZATION OF VARIANT
RP   LEU-125, AND TISSUE SPECIFICITY.
RX   PubMed=33988247; DOI=10.1111/cge.13995;
RA   Sha Y., Liu W., Wei X., Zhu X., Tang B., Zhang X., Yang X., Wang Y.,
RA   Wang X.;
RT   "Pathogenic variants of ATG4D in infertile men with non-obstructive
RT   azoospermia identified using whole-exome sequencing.";
RL   Clin. Genet. 100:280-291(2021).
CC   -!- FUNCTION: [Cysteine protease ATG4D]: Cysteine protease that plays a key
CC       role in autophagy by mediating both proteolytic activation and
CC       delipidation of ATG8 family proteins (PubMed:21177865, PubMed:29458288,
CC       PubMed:30661429). The protease activity is required for proteolytic
CC       activation of ATG8 family proteins: cleaves the C-terminal amino acid
CC       of ATG8 proteins MAP1LC3 and GABARAPL2, to reveal a C-terminal glycine
CC       (PubMed:21177865). Exposure of the glycine at the C-terminus is
CC       essential for ATG8 proteins conjugation to phosphatidylethanolamine
CC       (PE) and insertion to membranes, which is necessary for autophagy (By
CC       similarity). In addition to the protease activity, also mediates
CC       delipidation of ATG8 family proteins (PubMed:29458288,
CC       PubMed:33909989). Catalyzes delipidation of PE-conjugated forms of ATG8
CC       proteins during macroautophagy (PubMed:29458288, PubMed:33909989). Also
CC       involved in non-canonical autophagy, a parallel pathway involving
CC       conjugation of ATG8 proteins to single membranes at endolysosomal
CC       compartments, by catalyzing delipidation of ATG8 proteins conjugated to
CC       phosphatidylserine (PS) (PubMed:33909989). ATG4D plays a role in the
CC       autophagy-mediated neuronal homeostasis in the central nervous system
CC       (By similarity). Compared to other members of the family (ATG4A, ATG4B
CC       or ATG4C), constitutes the major protein for the delipidation activity,
CC       while it promotes weak proteolytic activation of ATG8 proteins (By
CC       similarity). Involved in phagophore growth during mitophagy
CC       independently of its protease activity and of ATG8 proteins: acts by
CC       regulating ATG9A trafficking to mitochondria and promoting phagophore-
CC       endoplasmic reticulum contacts during the lipid transfer phase of
CC       mitophagy (PubMed:33773106). {ECO:0000250|UniProtKB:Q8BGV9,
CC       ECO:0000250|UniProtKB:Q9Y4P1, ECO:0000269|PubMed:21177865,
CC       ECO:0000269|PubMed:29458288, ECO:0000269|PubMed:30661429,
CC       ECO:0000269|PubMed:33773106, ECO:0000269|PubMed:33909989}.
CC   -!- FUNCTION: [Cysteine protease ATG4D, mitochondrial]: Plays a role as an
CC       autophagy regulator that links mitochondrial dysfunction with
CC       apoptosis. The mitochondrial import of ATG4D during cellular stress and
CC       differentiation may play important roles in the regulation of
CC       mitochondrial physiology, ROS, mitophagy and cell viability.
CC       {ECO:0000269|PubMed:19549685, ECO:0000269|PubMed:22441018}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-C-terminal L-amino acid-glycyl-
CC         phosphatidylethanolamide + H2O = [protein]-C-terminal L-amino acid-
CC         glycine + a 1,2-diacyl-sn-glycero-3-phosphoethanolamine;
CC         Xref=Rhea:RHEA:67548, Rhea:RHEA-COMP:17323, Rhea:RHEA-COMP:17324,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:64612, ChEBI:CHEBI:172940,
CC         ChEBI:CHEBI:172941; Evidence={ECO:0000269|PubMed:29458288,
CC         ECO:0000269|PubMed:33909989};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67549;
CC         Evidence={ECO:0000269|PubMed:29458288, ECO:0000269|PubMed:33909989};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-C-terminal L-amino acid-glycyl-phosphatidylserine +
CC         H2O = [protein]-C-terminal L-amino acid-glycine + a 1,2-diacyl-sn-
CC         glycero-3-phospho-L-serine; Xref=Rhea:RHEA:67576, Rhea:RHEA-
CC         COMP:17324, Rhea:RHEA-COMP:17326, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57262, ChEBI:CHEBI:172940, ChEBI:CHEBI:172942;
CC         Evidence={ECO:0000269|PubMed:33909989};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67577;
CC         Evidence={ECO:0000269|PubMed:33909989};
CC   -!- ACTIVITY REGULATION: Inhibited by N-ethylmaleimide.
CC       {ECO:0000269|PubMed:21177865}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=13.1 uM for MAP1LC3B {ECO:0000269|PubMed:21177865};
CC         KM=7.2 uM for GABARAPL2 {ECO:0000269|PubMed:21177865};
CC   -!- SUBCELLULAR LOCATION: [Cysteine protease ATG4D]: Cytoplasm
CC       {ECO:0000269|PubMed:19549685}.
CC   -!- SUBCELLULAR LOCATION: [Cysteine protease ATG4D, mitochondrial]:
CC       Cytoplasm {ECO:0000269|PubMed:19549685}. Mitochondrion matrix
CC       {ECO:0000269|PubMed:19549685, ECO:0000269|PubMed:22441018}.
CC       Note=Imported into mitochondrial matrix after cleavage by CASP3 during
CC       oxidative stress and cell death. {ECO:0000269|PubMed:22441018}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86TL0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86TL0-2; Sequence=VSP_056671;
CC   -!- TISSUE SPECIFICITY: Widely expressed in testis.
CC       {ECO:0000269|PubMed:33988247}.
CC   -!- DOMAIN: The cryptic mitochondrial transit peptide is revealed after
CC       cleavage by caspase upon oxidative stress and cell death
CC       (PubMed:22441018). It acts then as a functional transit peptide, and
CC       allows the import of the cleaved protein into the mitochondria
CC       (PubMed:22441018). {ECO:0000269|PubMed:22441018}.
CC   -!- PTM: Cleaved by CASP3 during apoptosis which leads to increased
CC       activity (PubMed:19549685, PubMed:22441018). The cleavage by CASP3
CC       reveals a cryptic mitochondrial targeting sequence immediately
CC       downstream of their canonical caspase cleavage sites which leads to
CC       mitochondrial import of the protein (PubMed:19549685, PubMed:22441018).
CC       {ECO:0000269|PubMed:19549685, ECO:0000269|PubMed:22441018}.
CC   -!- SIMILARITY: Belongs to the peptidase C54 family. {ECO:0000305}.
CC   -!- CAUTION: A paper describing ATG4D tissue expression has been retracted,
CC       due to concerns of image duplication in some of the figures.
CC       {ECO:0000269|PubMed:12446702, ECO:0000305|PubMed:30808002}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ312332; CAC85951.1; -; mRNA.
DR   EMBL; AC011461; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84116.1; -; Genomic_DNA.
DR   EMBL; BC007639; AAH07639.1; -; mRNA.
DR   EMBL; BC016845; AAH16845.1; -; mRNA.
DR   EMBL; BC068992; AAH68992.1; -; mRNA.
DR   CCDS; CCDS12241.1; -. [Q86TL0-1]
DR   RefSeq; NP_001268433.1; NM_001281504.1.
DR   RefSeq; NP_116274.3; NM_032885.5. [Q86TL0-1]
DR   RefSeq; XP_054178417.1; XM_054322442.1. [Q86TL0-1]
DR   AlphaFoldDB; Q86TL0; -.
DR   SMR; Q86TL0; -.
DR   BioGRID; 124401; 14.
DR   FunCoup; Q86TL0; 1348.
DR   IntAct; Q86TL0; 136.
DR   STRING; 9606.ENSP00000311318; -.
DR   MEROPS; C54.005; -.
DR   TCDB; 9.A.15.2.1; the autophagy-related phagophore-formation transporter (apt) family.
DR   GlyGen; Q86TL0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q86TL0; -.
DR   PhosphoSitePlus; Q86TL0; -.
DR   BioMuta; ATG4D; -.
DR   DMDM; 61211809; -.
DR   jPOST; Q86TL0; -.
DR   MassIVE; Q86TL0; -.
DR   PaxDb; 9606-ENSP00000311318; -.
DR   PeptideAtlas; Q86TL0; -.
DR   ProteomicsDB; 69710; -. [Q86TL0-1]
DR   ProteomicsDB; 75778; -.
DR   Antibodypedia; 25362; 583 antibodies from 37 providers.
DR   DNASU; 84971; -.
DR   Ensembl; ENST00000309469.9; ENSP00000311318.3; ENSG00000130734.10. [Q86TL0-1]
DR   GeneID; 84971; -.
DR   KEGG; hsa:84971; -.
DR   MANE-Select; ENST00000309469.9; ENSP00000311318.3; NM_032885.6; NP_116274.3.
DR   UCSC; uc002mov.5; human. [Q86TL0-1]
DR   AGR; HGNC:20789; -.
DR   CTD; 84971; -.
DR   DisGeNET; 84971; -.
DR   GeneCards; ATG4D; -.
DR   HGNC; HGNC:20789; ATG4D.
DR   HPA; ENSG00000130734; Low tissue specificity.
DR   MIM; 611340; gene.
DR   OpenTargets; ENSG00000130734; -.
DR   VEuPathDB; HostDB:ENSG00000130734; -.
DR   eggNOG; KOG2674; Eukaryota.
DR   GeneTree; ENSGT00530000063000; -.
DR   HOGENOM; CLU_021259_3_2_1; -.
DR   InParanoid; Q86TL0; -.
DR   OMA; MPRDWAW; -.
DR   OrthoDB; 2960936at2759; -.
DR   PAN-GO; Q86TL0; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q86TL0; -.
DR   PathwayCommons; Q86TL0; -.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   SABIO-RK; Q86TL0; -.
DR   SignaLink; Q86TL0; -.
DR   BioGRID-ORCS; 84971; 10 hits in 1152 CRISPR screens.
DR   ChiTaRS; ATG4D; human.
DR   GenomeRNAi; 84971; -.
DR   Pharos; Q86TL0; Tbio.
DR   PRO; PR:Q86TL0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q86TL0; protein.
DR   Bgee; ENSG00000130734; Expressed in mucosa of transverse colon and 97 other cell types or tissues.
DR   ExpressionAtlas; Q86TL0; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0070004; F:cysteine-type exopeptidase activity; IDA:UniProt.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0019786; F:protein-phosphatidylethanolamide deconjugating activity; IBA:GO_Central.
DR   GO; GO:0035973; P:aggrephagy; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0000045; P:autophagosome assembly; IDA:UniProt.
DR   GO; GO:0006914; P:autophagy; IDA:UniProtKB.
DR   GO; GO:0000423; P:mitophagy; IMP:UniProtKB.
DR   GO; GO:0034727; P:piecemeal microautophagy of the nucleus; IBA:GO_Central.
DR   GO; GO:0051697; P:protein delipidation; IDA:UniProtKB.
DR   GO; GO:0034497; P:protein localization to phagophore assembly site; IMP:UniProtKB.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR005078; Peptidase_C54.
DR   InterPro; IPR046792; Peptidase_C54_cat.
DR   PANTHER; PTHR22624; CYSTEINE PROTEASE ATG4; 1.
DR   PANTHER; PTHR22624:SF36; CYSTEINE PROTEASE ATG4D; 1.
DR   Pfam; PF03416; Peptidase_C54; 1.
DR   SUPFAM; SSF54001; Cysteine proteinases; 1.
DR   neXtProt; NX_Q86TL0; -.
DR   PharmGKB; PA134907475; -.
DR   TreeFam; TF314847; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Autophagy; Cytoplasm; Hydrolase;
KW   Mitochondrion; Phosphoprotein; Protease; Protein transport;
KW   Proteomics identification; Reference proteome; Thiol protease; Transport;
KW   Ubl conjugation pathway.
FT   CHAIN           1..474
FT                   /note="Cysteine protease ATG4D"
FT                   /id="PRO_0000215853"
FT   CHAIN           64..474
FT                   /note="Cysteine protease ATG4D, mitochondrial"
FT                   /id="PRO_0000423408"
FT   REGION          1..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          64..103
FT                   /note="Cryptic mitochondrial signal peptide"
FT   COMPBIAS        15..27
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        35..57
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        144
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4P1"
FT   ACT_SITE        356
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4P1"
FT   ACT_SITE        358
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4P1"
FT   SITE            63..64
FT                   /note="Cleavage; by CASP3"
FT                   /evidence="ECO:0000269|PubMed:19549685"
FT   MOD_RES         467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..333
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056671"
FT   VARIANT         125
FT                   /note="R -> L (found in patients with non-obstructive
FT                   azoospermia; uncertain significance; decreased expression
FT                   of MAP1LC3B; increased programmed cell death in
FT                   spermatogenic cells; dbSNP:rs1216040637)"
FT                   /evidence="ECO:0000269|PubMed:33988247"
FT                   /id="VAR_085353"
FT   VARIANT         273
FT                   /note="V -> I (found in patients with non-obstructive
FT                   azoospermia; uncertain significance; dbSNP:rs145807760)"
FT                   /evidence="ECO:0000269|PubMed:33988247"
FT                   /id="VAR_085354"
FT   VARIANT         295
FT                   /note="A -> D (found in patients with non-obstructive
FT                   azoospermia; uncertain significance; dbSNP:rs1261979779)"
FT                   /evidence="ECO:0000269|PubMed:33988247"
FT                   /id="VAR_085355"
FT   VARIANT         395
FT                   /note="V -> M (found in patients with non-obstructive
FT                   azoospermia; uncertain significance; dbSNP:rs201291151)"
FT                   /evidence="ECO:0000269|PubMed:33988247"
FT                   /id="VAR_085356"
FT   MUTAGEN         63
FT                   /note="D->A: Abolishes cleavage by CASP3."
FT                   /evidence="ECO:0000269|PubMed:19549685"
SQ   SEQUENCE   474 AA;  52922 MW;  DBD91A3F1F80D2B8 CRC64;
     MNSVSPAAAQ YRSSSPEDAR RRPEARRPRG PRGPDPNGLG PSGASGPALG SPGAGPSEPD
     EVDKFKAKFL TAWNNVKYGW VVKSRTSFSK ISSIHLCGRR YRFEGEGDIQ RFQRDFVSRL
     WLTYRRDFPP LPGGCLTSDC GWGCMLRSGQ MMLAQGLLLH FLPRDWTWAE GMGLGPPELS
     GSASPSRYHG PARWMPPRWA QGAPELEQER RHRQIVSWFA DHPRAPFGLH RLVELGQSSG
     KKAGDWYGPS LVAHILRKAV ESCSDVTRLV VYVSQDCTVY KADVARLVAR PDPTAEWKSV
     VILVPVRLGG ETLNPVYVPC VKELLRCELC LGIMGGKPRH SLYFIGYQDD FLLYLDPHYC
     QPTVDVSQAD FPLESFHCTS PRKMAFAKMD PSCTVGFYAG DRKEFETLCS ELTRVLSSSS
     ATERYPMFTL AEGHAQDHSL DDLCSQLAQP TLRLPRTGRL LRAKRPSSED FVFL
//
